Therapeutic Approach

Archive: April, 2015

Ritter Pharmaceuticals Names Gastroenterology Industry Veteran Gerald T. Proehl to its Board of Directors

LOS ANGELES (April 22, 2015) – Ritter Pharmaceuticals, Inc., a privately held pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced that Gerald T. Proehl has joined the Company’s Board of Directors. With his appointment, the Ritter Pharma Board now has seven Directors. Mr. Proehl will […]

Leave Your Comments »

Ritter Pharmaceuticals Names Paul V. Maier to its Board of Directors

LOS ANGELES (April 14, 2015) – Ritter Pharmaceuticals, Inc., a privately held pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, announces the appointment of Paul V. Maier to the Company’s Board of Directors. His addition increases Board membership to six directors. Mr. Maier will chair the Company’s […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD